Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience
British Journal of Radiology · 2026
DOI: 10.1093/bjr/tqag135 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2026. Verfasst von David John McMahon und 23 weiteren Autor:innen. Beteiligte Einrichtung: Lung Unit, Royal Marsden Hospital, Chelsea, London SW36JJ, United Kingdom. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Brain Neoplasms, Radiosurgery, Lung Neoplasms. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objectives
Approximately 60% of patients with small cell lung cancer (SCLC) develop brain metastases (BM). Historically these have been managed with whole brain radiotherapy. We sought to compare outcomes with the FIRE-SCLC study which provided a benchmark median overall survival of 8.5 months (m).
Methods
We conducted a retrospective analysis of a prospectively collected dataset of patients with SCLC receiving stereotactic radiosurgery (SRS) for BM at our center from May 2016 to October 2024. The primary objective was mOS. Survival analysis was calculated from time of first SRS to death, performed on Prism 10.1.1. Extraction from electronic medical records was undertaken by authors, with local R&D approval.
Results
Forty patients were evaluable and 20% of patients (N = 8/40) received multiple treatments. The median follow-up time was 8.7 m. The median OS was 10.0 m. mOS of patients with 1 lesion was 13.8 m, vs. 8.4 m and 8.7 m for 2-4 and 5-10 BM. mOS for patients with KPS ≥ 90 was 12.4 m vs. 8.7 m for those with KPS ≤ 80 (HR 1.63, P = .15). There was one death within 28 days of SRS. Five patients died within 90 days of SRS.
Conclusion
Median OS in this cohort of patients with SCLC BM compared favorably to the FIRE-SCLC cohort, supporting consideration in selected patients. Our cohort was limited by sample size. Further prospective research is needed to guide local therapies in ES-SCLC BM, particularly regarding adverse events. Advances in knowledge UK real-world data demonstrates survival outcomes with SRS for SCLC BM comparable to FIRE-SCLC, supporting feasibility under NHS commissioning criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lung Unit, Royal Marsden Hospital, Chelsea, London SW36JJ, United Kingdom.
- Division of Oncology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand.
- Neurooncology Unit, Royal Marsden Hospital, London SW36JJ, United Kingdom.
- Lung Unit, Royal Marsden Hospital, Sutton, Surrey SM25PT, United Kingdom.
ORCID-Profile: David John McMahon, James De Boisanger, Nicola Rosenfelder
Zitieren
APA
McMahon, D. J., John, A., Ketpueak, T., De Boisanger, J., Sachdeva, A., Brewer, M., Aykac, S., Yu, T., Nangendo, C., Kalofonou, F., Milner-Watts, C., Yousaf, N., Davidson, M., Bhosle, J., Minchom, A., O'Brien, M., Popat, S., Welsh, L., Creak, A., …, & Rosenfelder, N. (2026). Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag135
Vancouver
McMahon DJ, John A, Ketpueak T, De Boisanger J, Sachdeva A, Brewer M, et al. Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag135
BibTeX
@article{McMahon2026,
author = {McMahon, David John and John, Alexius and Ketpueak, Thanika and De Boisanger, James and Sachdeva, Aishani and Brewer, Martin and Aykac, Safa and Yu, Tamara and Nangendo, Christine and Kalofonou, Foteini and Milner-Watts, Charlotte and Yousaf, Nadia and Davidson, Michael and Bhosle, Jaishree and Minchom, Anna and O'Brien, Mary and Popat, Sanjay and Welsh, Liam and Creak, Antonia and Solda, Francesca and Taylor, Helen and Konadu, Jessica and Tokaca, Nadza and Rosenfelder, Nicola},
title = {Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience},
journal = {British Journal of Radiology},
year = {2026},
doi = {10.1093/bjr/tqag135}
}
EUVIMED